These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 11937576

  • 1. Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis.
    Tezak Z, Hoffman EP, Lutz JL, Fedczyna TO, Stephan D, Bremer EG, Krasnoselska-Riz I, Kumar A, Pachman LM.
    J Immunol; 2002 Apr 15; 168(8):4154-63. PubMed ID: 11937576
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Myogenic Progenitor Cells Exhibit Type I Interferon-Driven Proangiogenic Properties and Molecular Signature During Juvenile Dermatomyositis.
    Gitiaux C, Latroche C, Weiss-Gayet M, Rodero MP, Duffy D, Bader-Meunier B, Glorion C, Nusbaum P, Bodemer C, Mouchiroud G, Chelly J, Germain S, Desguerre I, Chazaud B.
    Arthritis Rheumatol; 2018 Jan 15; 70(1):134-145. PubMed ID: 28941175
    [Abstract] [Full Text] [Related]

  • 4. Muscle Expression of Type I and Type II Interferons Is Increased in Juvenile Dermatomyositis and Related to Clinical and Histologic Features.
    Moneta GM, Pires Marafon D, Marasco E, Rosina S, Verardo M, Fiorillo C, Minetti C, Bracci-Laudiero L, Ravelli A, De Benedetti F, Nicolai R.
    Arthritis Rheumatol; 2019 Jun 15; 71(6):1011-1021. PubMed ID: 30552836
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Does HLA-dependent chimerism underlie the pathogenesis of juvenile dermatomyositis?
    Reed AM, McNallan K, Wettstein P, Vehe R, Ober C.
    J Immunol; 2004 Apr 15; 172(8):5041-6. PubMed ID: 15067086
    [Abstract] [Full Text] [Related]

  • 7. Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies.
    Kim H, Gunter-Rahman F, McGrath JA, Lee E, de Jesus AA, Targoff IN, Huang Y, O'Hanlon TP, Tsai WL, Gadina M, Miller FW, Goldbach-Mansky R, Rider LG.
    Arthritis Res Ther; 2020 Apr 06; 22(1):69. PubMed ID: 32252809
    [Abstract] [Full Text] [Related]

  • 8. MxA gene expression in juvenile dermatomyositis peripheral blood mononuclear cells: association with muscle involvement.
    O'Connor KA, Abbott KA, Sabin B, Kuroda M, Pachman LM.
    Clin Immunol; 2006 Sep 06; 120(3):319-25. PubMed ID: 16859997
    [Abstract] [Full Text] [Related]

  • 9. Expression of the OAS Gene Family Is Highly Modulated in Subjects Affected by Juvenile Dermatomyositis, Resembling an Immune Response to a dsRNA Virus Infection.
    Musumeci G, Castrogiovanni P, Barbagallo I, Tibullo D, Sanfilippo C, Nunnari G, Pellicanò GF, Pavone P, Caltabiano R, Di Marco R, Imbesi R, Di Rosa M.
    Int J Mol Sci; 2018 Sep 17; 19(9):. PubMed ID: 30227596
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap.
    Wedderburn LR, McHugh NJ, Chinoy H, Cooper RG, Salway F, Ollier WE, McCann LJ, Varsani H, Dunphy J, North J, Davidson JE, Juvenile Dermatomyositis Research Group (JDRG).
    Rheumatology (Oxford); 2007 Dec 17; 46(12):1786-91. PubMed ID: 18003662
    [Abstract] [Full Text] [Related]

  • 13. Immunogenetic studies in families of children with juvenile dermatomyositis.
    Reed AM, Pachman LM, Hayford J, Ober C.
    J Rheumatol; 1998 May 17; 25(5):1000-2. PubMed ID: 9598907
    [Abstract] [Full Text] [Related]

  • 14. Transcriptomes of peripheral blood mononuclear cells from juvenile dermatomyositis patients show elevated inflammation even when clinically inactive.
    Roberson EDO, Mesa RA, Morgan GA, Cao L, Marin W, Pachman LM.
    Sci Rep; 2022 Jan 07; 12(1):275. PubMed ID: 34997119
    [Abstract] [Full Text] [Related]

  • 15. Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis.
    Preuße C, Allenbach Y, Hoffmann O, Goebel HH, Pehl D, Radke J, Doeser A, Schneider U, Alten RH, Kallinich T, Benveniste O, von Moers A, Schoser B, Schara U, Stenzel W.
    Acta Neuropathol Commun; 2016 Apr 27; 4(1):45. PubMed ID: 27121733
    [Abstract] [Full Text] [Related]

  • 16. Juvenile dermatomyositis: the association of the TNF alpha-308A allele and disease chronicity.
    Pachman LM, Fedczyna TO, Lechman TS, Lutz J.
    Curr Rheumatol Rep; 2001 Oct 27; 3(5):379-86. PubMed ID: 11564368
    [Abstract] [Full Text] [Related]

  • 17. Elevated type I IFN signalling directly affects CD8+ T-cell distribution and autoantigen recognition of the skeletal muscles in active JDM patients.
    Huang B, Li H, Jiang Q, Li Y, Jiang Z, Cao H, Wang S, Wang X, Li J, Li G.
    J Autoimmun; 2024 Jun 27; 146():103232. PubMed ID: 38692172
    [Abstract] [Full Text] [Related]

  • 18. MHC class I and II expression in juvenile dermatomyositis skeletal muscle.
    Sallum AM, Kiss MH, Silva CA, Wakamatsu A, Sachetti S, Lotufo S, Matsumura N, Marie SK.
    Clin Exp Rheumatol; 2009 Jun 27; 27(3):519-26. PubMed ID: 19604449
    [Abstract] [Full Text] [Related]

  • 19. Increased expression of vascular cell adhesion molecule 1 in muscle biopsy samples from juvenile dermatomyositis patients with short duration of untreated disease is regulated by miR-126.
    Kim E, Cook-Mills J, Morgan G, Sredni ST, Pachman LM.
    Arthritis Rheum; 2012 Nov 27; 64(11):3809-17. PubMed ID: 22740338
    [Abstract] [Full Text] [Related]

  • 20. Immunogenetic associations in childhood dermatomyositis.
    Reed AM.
    Curr Rheumatol Rep; 2000 Jun 27; 2(3):212-5. PubMed ID: 11123061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.